Report for Hampel H

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (17)

Title : A Systematic Review of Clinical Practice Guidelines for Alzheimer's Disease and Strategies for Future Advancements - Tahami_2023_Neurol.Ther__
Author(s) : Tahami Monfared AA , Phan NTN , Pearson I , Mauskopf J , Cho M , Zhang Q , Hampel H
Ref : Neurol Ther , : , 2023
Abstract : Tahami_2023_Neurol.Ther__
ESTHER : Tahami_2023_Neurol.Ther__
PubMedSearch : Tahami_2023_Neurol.Ther__
PubMedID: 37261607

Title : Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer's disease: relevance for precision medicine in neurodegenerative diseases - Lista_2022_Ageing.Res.Rev__101819
Author(s) : Lista S , Vergallo A , Teipel SJ , Lemercier P , Giorgi FS , Gabelle A , Garaci F , Mercuri NB , Babiloni C , Gaire BP , Koronyo Y , Koronyo-Hamaoui M , Hampel H , Nistico R
Ref : Ageing Res Rev , :101819 , 2022
Abstract : Lista_2022_Ageing.Res.Rev__101819
ESTHER : Lista_2022_Ageing.Res.Rev__101819
PubMedSearch : Lista_2022_Ageing.Res.Rev__101819
PubMedID: 36526257

Title : Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research - Hampel_2019_J.Prev.Alzheimers.Dis_6_2
Author(s) : Hampel H , Mesulam MM , Cuello AC , Khachaturian AS , Vergallo A , Farlow MR , Snyder PJ , Giacobini E , Khachaturian ZS
Ref : J Prev Alzheimers Dis , 6 :2 , 2019
Abstract : Hampel_2019_J.Prev.Alzheimers.Dis_6_2
ESTHER : Hampel_2019_J.Prev.Alzheimers.Dis_6_2
PubMedSearch : Hampel_2019_J.Prev.Alzheimers.Dis_6_2
PubMedID: 30569080

Title : The cholinergic system in the pathophysiology and treatment of Alzheimer's disease - Hampel_2018_Brain_141_1917
Author(s) : Hampel H , Mesulam MM , Cuello AC , Farlow MR , Giacobini E , Grossberg GT , Khachaturian AS , Vergallo A , Cavedo E , Snyder PJ , Khachaturian ZS
Ref : Brain , 141 :1917 , 2018
Abstract : Hampel_2018_Brain_141_1917
ESTHER : Hampel_2018_Brain_141_1917
PubMedSearch : Hampel_2018_Brain_141_1917
PubMedID: 29850777

Title : Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology - Hampel_2018_J.Alzheimers.Dis_64_S47
Author(s) : Hampel H , Toschi N , Babiloni C , Baldacci F , Black KL , Bokde ALW , Bun RS , Cacciola F , Cavedo E , Chiesa PA , Colliot O , Coman CM , Dubois B , Duggento A , Durrleman S , Ferretti MT , George N , Genthon R , Habert MO , Herholz K , Koronyo Y , Koronyo-Hamaoui M , Lamari F , Langevin T , Lehericy S , Lorenceau J , Neri C , Nistico R , Nyasse-Messene F , Ritchie C , Rossi S , Santarnecchi E , Sporns O , Verdooner SR , Vergallo A , Villain N , Younesi E , Garaci F , Lista S
Ref : J Alzheimers Dis , 64 :S47 , 2018
Abstract : Hampel_2018_J.Alzheimers.Dis_64_S47
ESTHER : Hampel_2018_J.Alzheimers.Dis_64_S47
PubMedSearch : Hampel_2018_J.Alzheimers.Dis_64_S47
PubMedID: 29562524

Title : Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors - Teipel_2018_Front.Neurol_9_642
Author(s) : Teipel SJ , Cavedo E , Hampel H , Grothe MJ
Ref : Front Neurol , 9 :642 , 2018
Abstract : Teipel_2018_Front.Neurol_9_642
ESTHER : Teipel_2018_Front.Neurol_9_642
PubMedSearch : Teipel_2018_Front.Neurol_9_642
PubMedID: 30158893

Title : Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease - Cavedo_2017_Sci.Rep_7_11706
Author(s) : Cavedo E , Grothe MJ , Colliot O , Lista S , Chupin M , Dormont D , Houot M , Lehericy S , Teipel S , Dubois B , Hampel H
Ref : Sci Rep , 7 :11706 , 2017
Abstract : Cavedo_2017_Sci.Rep_7_11706
ESTHER : Cavedo_2017_Sci.Rep_7_11706
PubMedSearch : Cavedo_2017_Sci.Rep_7_11706
PubMedID: 28916821

Title : Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease - Teipel_2016_Neuropharmacol_108_128
Author(s) : Teipel SJ , Cavedo E , Grothe MJ , Lista S , Galluzzi S , Colliot O , Chupin M , Bakardjian H , Dormont D , Dubois B , Hampel H
Ref : Neuropharmacology , 108 :128 , 2016
Abstract : Teipel_2016_Neuropharmacol_108_128
ESTHER : Teipel_2016_Neuropharmacol_108_128
PubMedSearch : Teipel_2016_Neuropharmacol_108_128
PubMedID: 26876309

Title : Effects of rivastigmine on visual attention in subjects with amnestic mild cognitive impairment: A serial functional MRI activation pilot-study - Bokde_2016_Psychiatry.Res_249_84
Author(s) : Bokde AL , Cavedo E , Lopez-Bayo P , Lista S , Meindl T , Born C , Galluzzi S , Faltraco F , Dubois B , Teipel SJ , Reiser M , Moller HJ , Hampel H
Ref : Psychiatry Res , 249 :84 , 2016
Abstract : Bokde_2016_Psychiatry.Res_249_84
ESTHER : Bokde_2016_Psychiatry.Res_249_84
PubMedSearch : Bokde_2016_Psychiatry.Res_249_84
PubMedID: 26851974

Title : Treatment options for tauopathies - Karakaya_2012_Curr.Treat.Options.Neurol_14_126
Author(s) : Karakaya T , Fusser F , Prvulovic D , Hampel H
Ref : Curr Treat Options Neurol , 14 :126 , 2012
Abstract : Karakaya_2012_Curr.Treat.Options.Neurol_14_126
ESTHER : Karakaya_2012_Curr.Treat.Options.Neurol_14_126
PubMedSearch : Karakaya_2012_Curr.Treat.Options.Neurol_14_126
PubMedID: 22307450

Title : Galantamine for Alzheimer's disease - Prvulovic_2010_Expert.Opin.Drug.Metab.Toxicol_6_345
Author(s) : Prvulovic D , Hampel H , Pantel J
Ref : Expert Opin Drug Metab Toxicol , 6 :345 , 2010
Abstract : Prvulovic_2010_Expert.Opin.Drug.Metab.Toxicol_6_345
ESTHER : Prvulovic_2010_Expert.Opin.Drug.Metab.Toxicol_6_345
PubMedSearch : Prvulovic_2010_Expert.Opin.Drug.Metab.Toxicol_6_345
PubMedID: 20113148

Title : Long-term cost-effectiveness of donepezil for the treatment of Alzheimer's disease - Teipel_2007_Eur.Arch.Psychiatry.Clin.Neurosci_257_330
Author(s) : Teipel SJ , Ewers M , Reisig V , Schweikert B , Hampel H , Happich M
Ref : European Archives of Psychiatry & Clinical Neuroscience , 257 :330 , 2007
Abstract : Teipel_2007_Eur.Arch.Psychiatry.Clin.Neurosci_257_330
ESTHER : Teipel_2007_Eur.Arch.Psychiatry.Clin.Neurosci_257_330
PubMedSearch : Teipel_2007_Eur.Arch.Psychiatry.Clin.Neurosci_257_330
PubMedID: 17404699

Title : Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trial - Teipel_2006_Psychopharmacology.(Berl)_187_86
Author(s) : Teipel SJ , Drzezga A , Bartenstein P , Moller HJ , Schwaiger M , Hampel H
Ref : Psychopharmacology (Berl) , 187 :86 , 2006
Abstract : Teipel_2006_Psychopharmacology.(Berl)_187_86
ESTHER : Teipel_2006_Psychopharmacology.(Berl)_187_86
PubMedSearch : Teipel_2006_Psychopharmacology.(Berl)_187_86
PubMedID: 16767418

Title : [Modern therapy for dementia] - Padberg_2005_MMW.Fortschr.Med_147 Spec No 2_71
Author(s) : Padberg F , Moller HJ , Bottlender R , Hampel H
Ref : MMW Fortschr Med , 147 Spec No 2 :71 , 2005
Abstract : Padberg_2005_MMW.Fortschr.Med_147 Spec No 2_71
ESTHER : Padberg_2005_MMW.Fortschr.Med_147 Spec No 2_71
PubMedSearch : Padberg_2005_MMW.Fortschr.Med_147 Spec No 2_71
PubMedID: 15968877

Title : CSF markers for incipient Alzheimer's disease - Blennow_2003_Lancet.Neurol_2_605
Author(s) : Blennow K , Hampel H
Ref : Lancet Neurol , 2 :605 , 2003
Abstract : Blennow_2003_Lancet.Neurol_2_605
ESTHER : Blennow_2003_Lancet.Neurol_2_605
PubMedSearch : Blennow_2003_Lancet.Neurol_2_605
PubMedID: 14505582

Title : [Alzheimer patients. To treat with anti-dementia drugs in spite of unanswered questions] -
Author(s) : Padberg F , Hampel H , Moller HJ
Ref : MMW Fortschr Med , 143 :43 , 2001
PubMedID: 11824167

Title : Double-blind, randomized, placebo-controlled clinical trial on the efficacy and tolerability of a physostigmine patch in patients with senile dementia of the Alzheimer type - Moller_1999_Pharmacopsychiatry_32_99
Author(s) : Moller HJ , Hampel H , Hegerl U , Schmitt W , Walter K
Ref : Pharmacopsychiatry , 32 :99 , 1999
Abstract : Moller_1999_Pharmacopsychiatry_32_99
ESTHER : Moller_1999_Pharmacopsychiatry_32_99
PubMedSearch : Moller_1999_Pharmacopsychiatry_32_99
PubMedID: 10463377